1 Correction to: CNS Drugs https://doi.org/10.1007/s40263-018-0553-1
An Online First version of this article was made available online at http://link.springer.com/journal/40263/onlineFirst/page/1 on 24 August 2018. An error was subsequently identified in the article, and the following correction should be noted:
Author listing: The name of the second author, which previously read:
‘Karl Wisseman’
Should read:
‘Karl Wissemann’.
The original article has been corrected.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gudesblatt, M., Wissemann, K., Zarif, M. et al. Correction to: Improvement in Cognitive Function as Measured by NeuroTrax in Patients with Relapsing Multiple Sclerosis Treated with Natalizumab: A 2-Year Retrospective Analysis. CNS Drugs 32, 1183 (2018). https://doi.org/10.1007/s40263-018-0574-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40263-018-0574-9